M. Mcnutt

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.

A. Buist, W. Spitzer, B. Habbick, 1994, American journal of respiratory and critical care medicine.

The Use of β-Agonists and the Risk of Death and near Death from Asthma

Pierre Ernst, Samy Suissa, W O Spitzer, 1992 .

Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?

A. Buist, W. Spitzer, B. Hemmelgarn, 1993, The American review of respiratory disease.

Health Databases in Saskatchewan

P. Beck, W. Downey, W. Osei, 2002 .

Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use.

A. Buist, W. Spitzer, D. Cockcroft, 1992, JAMA.

Cohort Study of Incidence of Sudden Unexplained Death in Persons with Seizure Disorder Treated with Antiepileptic Drugs in Saskatchewan, Canada

J. Annegers, T. B. Cole, P. Tennis, 1995, Epilepsia.

The Use of β‐Agonists and the Risk of Death and Near Death from Asthma

Samy Suissa, W. Spitzer, D. Cockcroft, 1992 .

Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan.

D. Cockcroft, B. Habbick, M. McNutt, 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients

C. Korteweg, J. Gu, Juxiang Ye, 2008, The Journal of pathology.

Nested caseÐcontrol study of the effects of non- steroidal anti-inflammatory drugs on breast cancer risk and stage

J A Hanley, J. Hanley, J. Boivin, 2000 .

Clinical complexity and epidemiologic uncertainty in case-control research. Fenoterol and asthma management.

W. Spitzer, B. Hemmelgarn, D. Cockcroft, 1991, Chest.